GHK-Cu peptide serums: real wrinkle science or TikTok hype?

What's this video probably claiming?

Based on the caption, hashtags, and product name, this video almost certainly positions THOME's CPR Serum as a standout anti-aging product that visibly smooths fine lines. The creator is framing this as a personal discovery moment, the classic "you found it" hook that implies other products have failed where this one delivers. The #koreanpharmacy tag is doing real work here, lending a kind of clinical credibility by association. CPR Serum-type products in the peptide category typically center on GHK-Cu (copper tripeptide-1), a naturally occurring peptide in human plasma that declines significantly with age. The implied claim is almost certainly that this serum produces noticeable, visible skin smoothing, not just theoretical collagen support. That's a meaningful distinction when you're evaluating whether the marketing matches what peer-reviewed research actually supports. The "No. 1 wrinkle serum" framing suggests a comparative superiority claim, which is the kind of thing that deserves real scrutiny.

What does the science actually show?

GHK-Cu has a legitimate research base, which is more than you can say for most TikTok skincare ingredients. Pickart and Margolina (2018, Cosmetics) documented that GHK-Cu stimulates collagen, elastin, and glycosaminoglycan synthesis while activating wound repair mechanisms. A clinical study by Leyden et al. (2009, Journal of Cosmetic Dermatology) showed a 0.4% GHK-Cu cream reduced fine lines and improved skin density over 12 weeks in 67 subjects. Finkley et al. (2007, Journal of Cosmetic Dermatology) found similar results with a combination GHK-Cu formulation improving periorbital wrinkling. The numbers are real but modest. We're talking statistically significant reductions in wrinkle depth, not dramatic transformations. And critically, most studies use concentrations and formulations that may differ substantially from what's in any given commercial serum. Penetration depth matters enormously with peptides. A peptide sitting on your skin barrier is not the same as one reaching dermal fibroblasts.

Where does the social media noise diverge from clinical reality?

Here's where it gets complicated. TikTok wrinkle content almost universally shows before-and-after framing that implies results happening in days or weeks. The clinical studies showing GHK-Cu effects ran 12 weeks minimum, under controlled conditions, with standardized formulations and concentrations. A creator saying a serum is their "No. 1" pick after presumably a few weeks of use is not the same as a randomized controlled trial. The "Korean pharmacy" framing implies pharmaceutical-grade rigor, but cosmetic serums sold under that branding are still cosmetics, not drugs, meaning they are not subject to efficacy review by any regulatory body. There's also a formulation stability problem nobody on TikTok mentions: GHK-Cu degrades with improper pH, oxidation, and incompatible ingredients. Vitamin C, for example, can destabilize copper peptides. Whether CPR Serum addresses these formulation challenges is unknown without seeing the full ingredient list and stability data.

What should you actually know?

GHK-Cu is one of the more scientifically supported topical peptides in the anti-aging category. That is not a high bar, but it is a real one. If a product contains it at an effective concentration, around 0.1% to 2% based on available literature, and the formulation is pH-appropriate and stable, you may see modest improvements in fine line appearance over 8 to 12 weeks. "Smooths fine lines" as a claim is defensible at that threshold. "No. 1 wrinkle serum" is marketing, not science. You should also know that topical peptide serums are categorically different from peptide therapy involving injectable bioactive peptides like BPC-157, TB-500, or ipamorelin. Lumping them into the same category, as this video's metadata does, creates confusion about mechanism, bioavailability, and regulatory status. Topical GHK-Cu is a cosmetic ingredient. Injectable peptide protocols are an entirely different clinical territory and should be approached with medical supervision, not TikTok recommendations.